Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Organogenesis Holdings (ORGO) Change in Inventory (2018 - 2025)

Organogenesis Holdings (ORGO) has 8 years of Change in Inventory data on record, last reported at $3.0 million in Q4 2025.

  • For Q4 2025, Change in Inventory rose 550.77% year-over-year to $3.0 million; the TTM value through Dec 2025 reached $17.9 million, up 188.77%, while the annual FY2025 figure was $17.9 million, 188.77% up from the prior year.
  • Change in Inventory reached $3.0 million in Q4 2025 per ORGO's latest filing, up from -$938000.0 in the prior quarter.
  • Across five years, Change in Inventory topped out at $8.7 million in Q1 2025 and bottomed at -$2.7 million in Q2 2024.
  • Average Change in Inventory over 5 years is $2.6 million, with a median of $2.6 million recorded in 2023.
  • Peak YoY movement for Change in Inventory: surged 2803.75% in 2023, then plummeted 241.39% in 2024.
  • A 5-year view of Change in Inventory shows it stood at -$439000.0 in 2021, then surged by 584.74% to $2.1 million in 2022, then plummeted by 66.82% to $706000.0 in 2023, then crashed by 35.55% to $455000.0 in 2024, then surged by 550.77% to $3.0 million in 2025.
  • Per Business Quant database, its latest 3 readings for Change in Inventory were $3.0 million in Q4 2025, -$938000.0 in Q3 2025, and $7.2 million in Q2 2025.